A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Clinical trial NCT06264921 · TERMINATED

Trial details

NCT number: NCT06264921
Sponsor: NiKang Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Solid Tumor, Adult Advanced Solid Tumor Metastatic Tumor Ovarian Cancer Ovarian Neoplasms Ovarian Carcinoma Metastatic Ovarian Carcinoma Endometrial Cancer Endometrial Neoplasms Endometrial Diseases Metastatic Endometrial Cancer

Start date: 2024-02-23
Primary completion: 2025-04-07
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.